Boardroom Alpha
8-K primary document
SYK · Current Report (Form 8-K) · Filed December 4, 2025

Stryker Corp8-K exhibit

d78127dex101.htm
EX-10.1

Exhibit 10.1

 

LOGO

Kevin A. Lobo

Chair and CEO

December 2, 2025

Spencer Stiles

Subj: Promotion and Compensation Changes

Dear Spencer,

It is with pleasure that I confirm your promotion to President and Chief Operating Officer, effective January 1, 2026. A summary of the compensation package related to your new role is as follows:

Annualized Base Salary and Bonus Target

 

 

Your annualized Base Salary will increase to $1,000,000.

 

This pay increase will be effective January 1, 2026.

 

Your annualized Bonus Target will be $1,000,000 (100% of your annualized Base Salary).

 

You are scheduled to receive a performance review in February 2027, and you are eligible for a merit increase in March 2027 based upon your performance. Subsequent reviews will be conducted annually.

2026 Stock Award

 

 

A recommendation will be made that the Compensation and Human Capital Committee of the Board approve an award to you of stock options and performance stock units (PSUs) under Stryker’s Long-Term Incentive Plan in February 2026. The target amount granted to you under this recommendation will be approximately $6,000,000 in award date value, comprised of 60% in PSUs and 40% in stock options. Except as otherwise provided in the Terms and Conditions, stock options would have a ten-year term and vest as to 20% of the underlying shares on each of the first five anniversary dates of the grant date. Vesting of any PSUs occurs on March 21 of the year following the three-year performance cycle, with the amount of shares earned subject to the achievement of pre-established performance goals.

As you already work for Stryker, you understand that by accepting this position, other provisions of your employment relationship with Stryker will continue in effect, meaning that you agree to abide by the requirements and guidelines set forth in Stryker’s Code of Conduct and other policies (including but not limited to guidelines concerning Conflicts of Interest), Stryker’s Employee Handbook and the terms of Stryker’s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement that you signed. You also acknowledge that you are aware of Stryker’s at-will employment relationship with you.

Congratulations on your new role. I look forward to your future contributions toward positioning Stryker for success.

Sincerely,

/s/ Kevin A. Lobo

Kevin A. Lobo

Chair and Chief Executive Officer


LOGO

I accept this offer of employment with Stryker and agree to the terms and conditions outlined in this letter:

/s/ Spencer S. Stiles

Spencer S. Stiles

12/2/2025

Date

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer